IDEXX Laboratories, Inc. (IDXX)
Automate Your Wheel Strategy on IDXX
With Tiblio's Option Bot, you can configure your own wheel strategy including IDXX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol IDXX
- Rev/Share 52.0302
- Book/Share 19.4914
- PB 38.6262
- Debt/Equity 0.1643
- CurrentRatio 1.1799
- ROIC 0.3809
- MktCap 60118469330.0
- FreeCF/Share 11.9054
- PFCF 63.0455
- PE 58.693
- Debt/Assets 0.0757
- DivYield 0
- ROE 0.6778
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | IDXX | Stifel | Hold | Buy | -- | $700 | Oct. 31, 2025 |
| Initiation | IDXX | UBS | -- | Neutral | -- | $720 | Oct. 1, 2025 |
| Reiterated | IDXX | BTIG Research | -- | Buy | $545 | $785 | Aug. 5, 2025 |
| Initiation | IDXX | Jefferies | -- | Buy | -- | $625 | July 1, 2025 |
News
Idexx (IDXX) Upgraded to Buy: Here's What You Should Know
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Idexx (IDXX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
What Makes Idexx Laboratories (IDXX) a Strong Momentum Stock: Buy Now?
Published: November 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
IDEXX Laboratories Vs ResMed: Which Stock Could Rally?
Published: November 24, 2025 by: Forbes
Sentiment: Neutral
IDEXX Laboratories' (IDXX) recent jump has investors questioning whether it's still the best bet—or if a stronger opportunity exists elsewhere. A closer look at its key competitor suggests there may be a clearer winner.
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
Published: November 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average
Published: November 20, 2025 by: Zacks Investment Research
Sentiment: Positive
From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
Published: November 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
Read More
Idexx Laboratories (IDXX) Just Flashed Golden Cross Signal: Do You Buy?
Published: November 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Idexx Laboratories (IDXX) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, IDXX broke through the 20-day moving average, which suggests a short-term bullish trend.
Read More
Idexx Laboratories (IDXX) Just Overtook the 50-Day Moving Average
Published: November 04, 2025 by: Zacks Investment Research
Sentiment: Positive
From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 50-day moving average, and this suggests a short-term bullish trend.
Read More
IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript
Published: November 03, 2025 by: Seeking Alpha
Sentiment: Neutral
IDEXX Laboratories, Inc. ( IDXX ) Q3 2025 Earnings Call November 3, 2025 8:30 AM EST Company Participants Andrew Emerson - Executive VP, CFO & Treasurer Jay Mazelsky - President, CEO & Director Conference Call Participants Erin Wilson Wright - Morgan Stanley, Research Division Michael Ryskin - BofA Securities, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Christopher Schott - JPMorgan Chase & Co, Research Division Daniel Christopher Clark - Leerink Partners LLC, Research Division Brandon Vazquez - William Blair & Company L.L.C., Research Division Andrea Zayco Narvaez Alfonso - UBS Investment Bank, Research Division Keith …
Read More
Idexx Stock Pops on Earnings. Pet Health Is Booming.
Published: November 03, 2025 by: Barrons
Sentiment: Positive
Vet visits are down, but growing revenue per visit is more than making up for it, the company says.
Read More
Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: October 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Here's How IDEXX Laboratories is Placed Ahead of Q3 Earnings
Published: October 20, 2025 by: Zacks Investment Research
Sentiment: Positive
IDXX heads into Q3 earnings with steady estimates and strong momentum across its diagnostics and pet healthcare segments.
Read More
Why Idexx (IDXX) is Poised to Beat Earnings Estimates Again
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term
Published: October 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
IDEXX Laboratories to Release 2025 Third Quarter Financial Results
Published: October 08, 2025 by: Business Wire
Sentiment: Neutral
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 third quarter financial results for Monday, November 3, 2025, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q3 2025 Earnings Snapshot through a link on the IDEXX websi.
Read More
HOLX vs. IDXX: Which Stock Is the Better Value Option?
Published: October 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic (HOLX) and Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
IDEXX Laboratories Stock Rallies 52.9% YTD: What's Behind the Drive?
Published: September 29, 2025 by: Zacks Investment Research
Sentiment: Positive
IDXX soars 52.9% YTD, fueled by strong CAG Diagnostics growth, global expansion and rising demand for software solutions.
Read More
Should You Add IDEXX Stock to Your Portfolio Right Now?
Published: September 12, 2025 by: Zacks Investment Research
Sentiment: Negative
IDXX shows strong CAG Diagnostics growth, cloud software momentum and global expansion but faces solvency and macro risks.
Read More
Why Is Idexx (IDXX) Down 0.4% Since Last Earnings Report?
Published: September 03, 2025 by: Zacks Investment Research
Sentiment: Negative
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
Read More
Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average
Published: August 29, 2025 by: Zacks Investment Research
Sentiment: Positive
From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
Read More
Should You Add IDEXX Stock to Your Portfolio Right Now?
Published: August 27, 2025 by: Zacks Investment Research
Sentiment: Neutral
IDXX gains from strong CAG Diagnostics growth and rising cloud software demand, but debt levels remain a concern for investors.
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
Published: August 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
IDEXX Gains 56.2% in a Year: What's Driving the Rally?
Published: August 25, 2025 by: Zacks Investment Research
Sentiment: Positive
IDXX shares surge 56.2% in a year, fueled by strong diagnostics growth, cloud software gains and an upbeat 2025 outlook.
Read More
Here's Why Idexx Laboratories (IDXX) is a Strong Momentum Stock
Published: August 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Is Idexx (IDXX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Published: August 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock
Published: August 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Why Idexx Laboratories (IDXX) is a Top Momentum Stock for the Long-Term
Published: August 06, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript
Published: August 04, 2025 by: Seeking Alpha
Sentiment: Neutral
IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q2 2025 Earnings Conference Call August 4, 2025 8:30 AM ET Company Participants Andrew Emerson - Executive VP, CFO & Treasurer Jonathan J. Mazelsky - President, CEO & Director Conference Call Participants Christopher Thomas Schott - JPMorgan Chase & Co, Research Division Daniel Christopher Clark - Leerink Partners LLC, Research Division David Michael Westenberg - Piper Sandler & Co., Research Division Erin Elizabeth Wilson Wright - Morgan Stanley, Research Division Jonathan David Block - Stifel, Nicolaus & Company, Incorporated, Research Division Michael Leonidovich Ryskin - BofA Securities, Research Division Navann Ty Dietschi - BNP Paribas …
Read More
Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF
Published: August 04, 2025 by: CNBC Television
Sentiment: Neutral
The Investment Committee gives you their top stocks to watch for the second half.
Read More
Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More
Published: August 04, 2025 by: Investopedia
Sentiment: Positive
U.S. equities were higher at midday, bouncing back from Friday's employment report-related selloff, and on news the European Union would delay new tariffs on U.S. goods. The Dow Jones Industrial Average, S&P 500, and Nasdaq all rose.
Read More
About IDEXX Laboratories, Inc. (IDXX)
- IPO Date 1991-06-21
- Website https://www.idexx.com
- Industry Medical - Diagnostics & Research
- CEO Jonathan J. Mazelsky
- Employees 11000